Skip to main content
. Author manuscript; available in PMC: 2014 Dec 2.
Published in final edited form as: Semin Arthritis Rheum. 2014 May 9;44(2):170–174. doi: 10.1016/j.semarthrit.2014.05.007

Table 1.

Definitions of treatment failure

Definition Patient group Possible mechanisms
Inadequate response Patients who fail to reach
target SU on allopurinol
Non-adherence
Under dosing
Partial resistance
Partial resistance Adherent patients on
“standard” allopurinol doses
(≤300mg daily) who fail to
achieve target SU
Impaired absorption
Decreased conversion of allopurinol
to oxypurinol
Efficient renal excretion of oxypurinol
Abnormality in XO structure and or
function such that oxypurinol is
rendered less effective
Drug interactions